About Merative
Merative was formed in 2022 after the acquisition of IBM Watson Health by Francisco Partners. The company provides healthcare data, analytics, clinical decision support, and population health solutions for providers, payers, employers, and government agencies. Its portfolio includes products such as Micromedex, MarketScan, and Merge imaging solutions. Merative leverages advanced analytics and AI capabilities inherited from IBM Watson Health to improve care quality and operational efficiency. The company focuses on evidence-based insights and interoperability across healthcare systems.